Progress and prospects for herpesvirus vaccination using gB antigens
The success of vaccines against varicella zoster virus (VZV) demonstrates the feasibility of high-level efficacy against clinical consequences of herpesvirus infection, but there is a need for new vaccines against others – in particular Epstein-Barr Virus (EBV), human cytomegalovirus (HCMV) and herp...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Frontiers Media S.A.
2026-05-01
|
| Ráidu: | Frontiers in Immunology |
| Fáttát: | |
| Liŋkkat: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1827628/full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|